These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 145540)

  • 1. Sarcoid granulomas associated with phenylbutazone treatment.
    Lebacq EG; Desmet V
    Mt Sinai J Med; 1977; 44(6):778-81. PubMed ID: 145540
    [No Abstract]   [Full Text] [Related]  

  • 2. Allopurinol-induced granulomatous hepatitis with cholangitis and a sarcoid-like reaction.
    Swank LA; Chejfec G; Nemchausky BA
    Arch Intern Med; 1978 Jun; 138(6):997-8. PubMed ID: 646570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liver damage due to phenylbutazone and chlorpropamide].
    Grottum KA
    Tidsskr Nor Laegeforen; 1966 Aug; 86(16):1096-8. PubMed ID: 5919203
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal hepatitis due to phenylbutazone in a child.
    Dhatt PS; Singh H; Gupta HL; Arya RK
    Indian J Pediatr; 1973 Aug; 40(307):293-4. PubMed ID: 4769816
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenylbutazone and hepatitis.
    Fowler PD; Woolf D; Alexander S
    Rheumatol Rehabil; 1975 May; 14(2):71-5. PubMed ID: 1145012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic hepatitis following phenylbutazone therapy.
    Muscat-Baron JM; Freeman DM
    Br J Clin Pract; 1966 Aug; 20(8):437-9. PubMed ID: 5944035
    [No Abstract]   [Full Text] [Related]  

  • 7. Granulomas and cholestatic--hepatocellular injury associated with phenylbutazone. Report of two cases.
    Ishak KG; Kirchner JP; Dhar JK
    Am J Dig Dis; 1977 Jul; 22(7):611-7. PubMed ID: 879127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological aspects of hepatitis induced by phenylbutazone derivatives. Observations on two cases.
    Coltorti M; Cuccurullo L; Del Vecchio Blanco C
    Acta Hepatosplenol; 1971; 18(3):206-15. PubMed ID: 5089187
    [No Abstract]   [Full Text] [Related]  

  • 9. [Improved compatibility of phenylbutazone drugs. A new antirheumatic agent in sugar-coated tablets, suppositories, ampoules].
    Dürrigl T; Vitaus M
    Munch Med Wochenschr; 1969 Mar; 111(10):564-8. PubMed ID: 4239143
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple manifestations of intolerance of a combination of anti-inflammatory drugs. Role of phenylbutazone].
    Tolot F; Prost G; Guignot B; Pelletier M
    Sem Hop; 1975 Dec; 51(48):2555-60. PubMed ID: 175502
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute interstitial nephritis with oliguric renal failure following phenylbutazone medication].
    Kuhlmann U; Fontana A; Briner J; Steinemann U; Siegenthaler W
    Schweiz Med Wochenschr; 1978 Apr; 108(13):494-9. PubMed ID: 147510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-steroidal antirheumatic therapy and the liver].
    Frank O
    Acta Med Austriaca; 1975; 2(4):145-8. PubMed ID: 1224930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic cholestasis due to benetazone].
    Krtek V; Chlumský J
    Vnitr Lek; 1979 Feb; 25(2):152-4. PubMed ID: 570757
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenylbutazone-induced hepatitis.
    Mayer TR
    Minn Med; 1979 May; 62(5):349-50. PubMed ID: 440260
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenylbutazone in treatment of acute lumbago-sciatica.
    Grevsten S; Johansson H
    Z Rheumatol; 1975; 34(11-12):444-7. PubMed ID: 128937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Granulomatous liver disease induced by phenylbutazone].
    Anker N; Skovbjerg H
    Ugeskr Laeger; 1975 Dec; 137(51):3038-9. PubMed ID: 1198751
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug-induced lesion of the liver].
    Ivlev AS; Polunina TE
    Voen Med Zh; 1987 Jun; (6):60-1. PubMed ID: 3660719
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature.
    Benjamin SB; Ishak KG; Zimmerman HJ; Grushka A
    Hepatology; 1981; 1(3):255-63. PubMed ID: 7286906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung changes associated with phenylbutazone treatment.
    Thurston JG; Marks P; Trapnell D
    Br Med J; 1976 Dec; 2(6049):1422-3. PubMed ID: 1009358
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of phenylbutazone on patients with acute lumbago-sciatica. A double blind trial.
    Weber H; Aasand G
    J Oslo City Hosp; 1980 May; 30(5):69-72. PubMed ID: 6446598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.